转移性胰腺神经内分泌肿瘤的临床试验
总计5834个结果
-
The Netherlands Cancer InstituteMerck Sharp & Dohme LLC未知
-
Altor BioScienceNational Cancer Institute (NCI)完全的
-
SCRI Development Innovations, LLCNovartis完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)完全的
-
Cooperative Research Centre for Biomedical Imaging...未知
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; Assign Data Management and Biostatistics GmbH完全的神经内分泌癌,3 级 | 低分化恶性神经内分泌癌 | 转为 G3 的 1 级神经内分泌癌 [分化良好的神经内分泌癌] | 转为 G3 的 2 级神经内分泌癌 [中度分化神经内分泌癌] | 神经内分泌肿瘤,3 级和疾病进展,根据实体瘤反应评估标准 (RECIST 1.1.) 衡量德国
-
California Pacific Medical Center Research InstituteM.D. Anderson Cancer Center招聘中
-
California Pacific Medical Center Research InstituteTesaro, Inc.; Vanderbilt-Ingram Cancer Center; Huntsman Cancer Institute招聘中
-
Hoffmann-La Roche完全的转移性黑色素瘤美国, 加拿大, 比利时, 西班牙, 法国, 俄罗斯联邦, 澳大利亚
-
Parker Institute for Cancer ImmunotherapySeres Therapeutics, Inc.完全的
-
University of LouisvilleJames Graham Brown Cancer Center主动,不招人
-
Abramson Cancer Center of the University of Pennsylvania完全的
-
Novartis Pharmaceuticals完全的
-
Hoffmann-La Roche完全的
-
University Hospital, MontpellierSaint-Louis Hospital, Paris, France完全的
-
John KirkwoodNational Cancer Institute (NCI); National Institutes of Health (NIH)终止
-
University of IowaNovartis Pharmaceuticals; Holden Comprehensive Cancer Center终止
-
Beth Israel Deaconess Medical CenterGenzyme, a Sanofi Company完全的
-
University of PittsburghBristol-Myers Squibb撤销
-
Italian Network for Tumor Biotherapy FoundationAstex Pharmaceuticals, Inc.未知